Načítá se...
Apoptosis of cancer cells is triggered by selective crosslinking and inhibition of receptor tyrosine kinases
Receptor tyrosine kinases (RTK) have been the most prevalent therapeutic targets in anti-cancer drug development. However, the emergence of drug resistance toward single target RTK inhibitors remains a major challenge to achieve long-term remissions. Development of alternative RTK inhibitory strateg...
Uloženo v:
| Vydáno v: | Commun Biol |
|---|---|
| Hlavní autoři: | , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Nature Publishing Group UK
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6588694/ https://ncbi.nlm.nih.gov/pubmed/31263775 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s42003-019-0484-5 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|